ZA200207002B - Salmonella vaccine materials and methods. - Google Patents

Salmonella vaccine materials and methods.

Info

Publication number
ZA200207002B
ZA200207002B ZA200207002A ZA200207002A ZA200207002B ZA 200207002 B ZA200207002 B ZA 200207002B ZA 200207002 A ZA200207002 A ZA 200207002A ZA 200207002 A ZA200207002 A ZA 200207002A ZA 200207002 B ZA200207002 B ZA 200207002B
Authority
ZA
South Africa
Prior art keywords
methods
salmonella vaccine
vaccine materials
materials
salmonella
Prior art date
Application number
ZA200207002A
Other languages
English (en)
Inventor
David E Lowery
Michael J Kennedy
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA200207002B publication Critical patent/ZA200207002B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200207002A 2000-03-17 2002-08-30 Salmonella vaccine materials and methods. ZA200207002B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19017800P 2000-03-17 2000-03-17

Publications (1)

Publication Number Publication Date
ZA200207002B true ZA200207002B (en) 2004-03-31

Family

ID=22700305

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200207002A ZA200207002B (en) 2000-03-17 2002-08-30 Salmonella vaccine materials and methods.

Country Status (17)

Country Link
US (2) US6923957B2 (da)
EP (1) EP1267899B1 (da)
JP (1) JP2003527433A (da)
AR (1) AR027680A1 (da)
AT (1) ATE300949T1 (da)
AU (2) AU5695701A (da)
BR (1) BR0109322A (da)
CA (1) CA2402252A1 (da)
DE (1) DE60112413T2 (da)
DK (1) DK1267899T3 (da)
ES (1) ES2244617T3 (da)
MX (1) MXPA02008748A (da)
NZ (1) NZ521425A (da)
PE (1) PE20011180A1 (da)
PT (1) PT1267899E (da)
WO (1) WO2001070247A2 (da)
ZA (1) ZA200207002B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0109322A (pt) * 2000-03-17 2002-12-10 Upjohn Co Materiais e métodos de vacina de salmonella
AU2004204751A1 (en) * 2003-01-09 2004-07-29 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
CN1297315C (zh) * 2004-11-25 2007-01-31 上海交通大学 抗仔猪细菌性疫病复合卵黄抗体制剂的制备方法
ATE545701T1 (de) * 2005-05-17 2012-03-15 Ozgene Pty Ltd Sequentielles klonierungssystem
US20070191736A1 (en) * 2005-10-04 2007-08-16 Don Alden Method for loading penetrating members in a collection device
EP2517723B1 (en) 2006-09-18 2019-11-06 The Board of Trustees of The University of Arkansas Compositions and methods of enhancing immune responses
UA100370C2 (uk) * 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
BRPI0818736A2 (pt) * 2007-10-30 2017-06-13 Univ Arkansas composições e métodos para intensificar imunorrepostas à bactéria flagelada
WO2009059298A2 (en) 2007-11-01 2009-05-07 Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancinc immune responses to eimeria
CA2703519C (en) 2007-11-09 2017-04-18 The Salk Institute For Biological Studies Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
CN102811734B (zh) 2010-01-21 2016-02-10 阿肯色大学评议会 增强免疫应答的疫苗载体和方法
CA2800830C (en) 2010-06-09 2020-09-08 The Board Of Trustees Of The University Of Arkansas Vaccine and methods to reduce campylobacter infection
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
US8481052B2 (en) 2011-05-17 2013-07-09 Cj Cheiljedang Corporation Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same
US9950053B2 (en) 2012-10-22 2018-04-24 The Board Of Regents For Oklahoma State University Use of the Salmonella SPP type III secretion proteins as a protective vaccination
US20150238590A1 (en) * 2012-10-22 2015-08-27 The Board Of Regents For Oklahoma State University Use of the salmonella spp type iii secretion proteins as a protective vaccination
US10548962B2 (en) 2012-10-22 2020-02-04 The Board Of Regents For Oklahoma State University Use of the salmonella SPP type III secretion proteins as a protective vaccination
HUE047484T2 (hu) 2013-02-14 2020-04-28 Univ Arkansas Készítmények és eljárások eimeria elleni immunválasz fokozására vagy eimeria-fertõzés korlátozására
US10376571B2 (en) 2013-03-15 2019-08-13 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to enteric pathogens
US20170333493A1 (en) * 2014-11-11 2017-11-23 Ohio State Innovation Foundation Probiotic bacteria for the prevention and treatment of salmonella
US20170072042A1 (en) * 2015-09-16 2017-03-16 Boehringer Ingelheim Vetmedica, Inc. Salmonella choleraesuis-salmonella typhimurium vaccines
KR20190015712A (ko) 2016-05-03 2019-02-14 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US4877612A (en) 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
ES2039229T3 (es) 1986-01-14 1993-09-16 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Procedimiento para la preparacion de complejos inmunogenicos y composiciones farmaceuticas que contienen estos complejos.
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
SG119177A1 (en) 1994-12-09 2006-02-28 Imp College Innovations Ltd Identification of genes
ATE403728T1 (de) * 1998-09-04 2008-08-15 Emergent Product Dev Uk Ltd Attenuierte salmonella spi2 mutante als antigen- träger
NZ519477A (en) 1999-12-23 2004-04-30 Microscience Ltd Attenuated microorganisms for the treatment of infection
BR0109322A (pt) * 2000-03-17 2002-12-10 Upjohn Co Materiais e métodos de vacina de salmonella

Also Published As

Publication number Publication date
US6923957B2 (en) 2005-08-02
CA2402252A1 (en) 2001-09-27
NZ521425A (en) 2004-05-28
WO2001070247A3 (en) 2002-04-18
AU5695701A (en) 2001-10-03
EP1267899B1 (en) 2005-08-03
DE60112413T2 (de) 2006-06-01
ATE300949T1 (de) 2005-08-15
US20040009191A1 (en) 2004-01-15
DK1267899T3 (da) 2005-12-12
WO2001070247A2 (en) 2001-09-27
BR0109322A (pt) 2002-12-10
JP2003527433A (ja) 2003-09-16
US20050260223A1 (en) 2005-11-24
PT1267899E (pt) 2005-11-30
PE20011180A1 (es) 2001-11-15
ES2244617T3 (es) 2005-12-16
DE60112413D1 (de) 2005-09-08
EP1267899A2 (en) 2003-01-02
AU2001256957B2 (en) 2005-08-25
AR027680A1 (es) 2003-04-09
MXPA02008748A (es) 2003-02-24

Similar Documents

Publication Publication Date Title
AU5695701A (en) Salmonella vaccine materials and methods
EG24742A (en) Vaccine composition.
ZA200207589B (en) Multivalent antibodies and uses therefor. Multivalent antibodies and uses thereof.
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
HUP0402067A3 (en) Vaccines
GB0020953D0 (en) Vaccine
HUP0301092A3 (en) Vaccine
AU9667901A (en) Mycoattractants and mycopesticides
PL362964A1 (en) Vaccine
HUP0301076A3 (en) Linezolid-crystal form ii and preparation thereof
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
ZA200101012B (en) Pharmaceutical combinations.
GB0024200D0 (en) Component vaccine
HUP0302612A3 (en) Salmonella vaccine
GB0014288D0 (en) Vaccine
GB0014845D0 (en) Vaccine
GB0026334D0 (en) Vaccine
AU2001261534A1 (en) The meca-79 antigen and related methods
IL152808A0 (en) Vaccines, immunotherapeutics and methods for using the same
GB0003082D0 (en) Vaccine
GB0004533D0 (en) Vaccines
GB0030059D0 (en) Polypeptides, methods and means
GB0015722D0 (en) Vaccine
GB0006693D0 (en) Vaccine
GB0027433D0 (en) Vaccine component